Healtcare Clinical Decision and Support System Market1

Clinical Decision and Support System Market
- Size, Share, Outlook, and Opportunity
Analysis, 2018 - 2026
Clinical Decision Support System (CDSS) is healthcare IT solution that provides evidence-based
information to provide optimum care to patient. Clinical decision support system assist healthcare
providers, by analyzing of patient data and using that information to aid in diagnosis of specific
disease and treatment plan for same. Information input offered by CDSS to clinicians and primary
care providers helps to improve the quality of the care by reducing drug overdose, drug interaction,
adverse events, and assisting in diagnosis.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2054
Market Dynamics
Major driver for growth of the clinical decision support system market is various benefits offered by
the CDSS in both inpatient settings, ambulatory settings, and clinics. Medical error is one of the
significant contributor to cause of death worldwide. According to data published by Centre for
Disease Control and Prevention (CDC), 2013, more than 150,000 deaths are reported annually in
the U.S. due to medical error (ADR, wrong diagnosis, prescription error)
According to World Health Organization (WHO) report, in 2017, medication error costs US$ 42
billion annually worldwide. An estimated 43 million patient safety incidence occur annually and
around 1 in 10 patient get harmed due to medication error while receiving healthcare. These
incidence of medication error could be addressed with use of CDSS. Increasing prevalence of
chronic disease is another driver for wide adoption of CDSS. According to WHO Factsheet, around
73% of global deaths are expected to be from chronic disease by 2020.